Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech : Mexico To Use Only Pfizer-BioNTech For At-Risk Children

09/24/2021 | 10:20am EDT


© MT Newswires 2021
All news about BIONTECH SE
12:00pBIONTECH : EMA Issues Positive Opinion For New Formulation Of BioNTech/Pfizer COVID-19 Vac..
MT
11:12aBIONTECH : New Formulation of COMIRNATY® Receives Positive Opinion from CHMP
PU
09:02aBIONTECH : Pfizer and BioNTech Submitted Data to EMA for the Vaccination of Children 5 to ..
PU
05:19aASTRAZENECA : EU has exported over 1 bln COVID-19 vaccines, von der Leyen says
RE
04:23aSINOVAC BIOTECH : Thailand to cease Sinovac vaccine use when stocks end this month
RE
10/15PFIZER : BioNTech ask EU agency to OK vaccine for kids 5-11
AQ
10/15PFIZER : BioNTech Makes European Medicines Agency Submission of Data Focusing COVID-19 Vac..
MT
10/15BIONTECH : Pfizer Seek European Medicines Agency's Approval for COVID-19 Vaccine for Young..
MT
10/15BIONTECH : Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12..
PU
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 684 M 19 360 M 19 360 M
Net income 2021 8 759 M 10 164 M 10 164 M
Net cash 2021 8 861 M 10 282 M 10 282 M
P/E ratio 2021 6,10x
Yield 2021 -
Capitalization 51 569 M 59 820 M 59 840 M
EV / Sales 2021 2,56x
EV / Sales 2022 1,86x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 213,52 €
Average target price 266,65 €
Spread / Average Target 24,9%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE203.83%59 820
GILEAD SCIENCES, INC.16.08%84 795
WUXI APPTEC CO., LTD.29.45%57 897
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156
BEIGENE, LTD.38.72%33 452